Misplaced Pages

Eberconazole

Clinical data
Trade names	Ebernet
Legal status
Legal status	US: Not FDA approved
Identifiers
IUPAC name 1-(1,3-Dichloro-6,11-dihydro-5H-dibenzo annulen-11-yl)imidazole
CAS Number	128326-82-9
PubChem CID	72051
ChemSpider	65038
UNII	V7O1U41C9B
CompTox Dashboard (EPA)	DTXSID90926104
Chemical and physical data
Formula	C18H14Cl2N2
Molar mass	329.22 g·mol
3D model (JSmol)	Interactive image
SMILES C1CC2=CC(=CC(=C2C(C3=CC=CC=C31)N4C=CN=C4)Cl)Cl
InChI InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2 Key:MPTJIDOGFUQSQH-UHFFFAOYSA-N

Eberconazole is an antifungal drug. As a 1% topical cream, it is an effective treatment for dermatophytosis, candidiasis, and pityriasis.

It was approved for use in Spain in 2015 and is sold under the trade name Ebernet. It is also approved for use in Panama, Guatemala, Costa Rica, Honduras, and the Dominican Republic.

References

1. ^ "Ebernet". NewBridge Pharmaceuticals. Archived from the original on 2016-04-24. Retrieved 2017-01-15.
2. del Palacio A, Ortiz FJ, Pérez A, Pazos C, Garau M, Font E (2001). "A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections". Mycoses. 44 (5): 173–80. doi:10.1046/j.1439-0507.2001.00632.x. PMID 11486455.
3. Repiso Montero T, López S, Rodríguez C, del Rio R, Badell A, Gratacós MR (May 2006). "Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream". International Journal of Dermatology. 45 (5): 600–4. doi:10.1111/j.1365-4632.2006.02841.x. PMID 16700802.
4. "Eberconazole". Drugs.com. Archived from the original on 2021-01-17. Retrieved 2017-01-15.

This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Imidazole antifungals
• Lanosterol 14α-demethylase inhibitors
• Dermatologic drug stubs